{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:51:00Z","timestamp":1792641060032,"version":"4.5.0"},"reference-count":31,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,3,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Very little is known about the role of metabolic regulatory mechanisms in platelet activation and thrombosis. Dimeric pyruvate kinase M2 (PKM2) is a crucial regulator of aerobic glycolysis that facilitates the production of lactate and metabolic reprogramming. Herein, we report that limiting PKM2 dimer formation, using the small molecule inhibitor ML265, negatively regulates lactate production and glucose uptake in human and murine stimulated platelets. Furthermore, limiting PKM2 dimer formation reduced agonist-induced platelet activation, aggregation, clot retraction, and thrombus formation under arterial shear stress in vitro in both human and murine platelets. Mechanistically, limiting PKM2 dimerization downregulated phosphatidylinositol 3-kinase (PI3K)-mediated protein kinase B or serine\/threonine-specific protein kinase (Akt)\/glycogen synthase kinase 3 (GSK3) signaling in human and murine platelets. To provide further evidence for the role of PKM2 in platelet function, we generated a megakaryocyte or platelet-specific PKM2\u2212\/\u2212 mutant strain (PKM2fl\/flPF4Cre+). Platelet-specific PKM2-deficient mice exhibited impaired agonist-induced platelet activation, aggregation, clot retraction, and PI3K-mediated Akt\/GSK3 signaling and were less susceptible to arterial thrombosis in FeCl3 injury\u2013induced carotid- and laser injury\u2013induced mesenteric artery thrombosis models, without altering hemostasis. Wild-type mice treated with ML265 were less susceptible to arterial thrombosis with unaltered tail bleeding times. These findings reveal a major role for PKM2 in coordinating multiple aspects of platelet function, from metabolism to cellular signaling to thrombosis, and implicate PKM2 as a potential target for antithrombotic therapeutic intervention.<\/jats:p>","DOI":"10.1182\/blood.2020007140","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T21:13:26Z","timestamp":1602105206000},"page":"1658-1668","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":78,"title":["The metabolic enzyme pyruvate kinase M2 regulates platelet function and arterial thrombosis"],"prefix":"10.1182","volume":"137","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6461-0543","authenticated-orcid":false,"given":"Manasa K.","family":"Nayak","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology\/Oncology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6606-0108","authenticated-orcid":false,"given":"Madankumar","family":"Ghatge","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology\/Oncology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4784-3094","authenticated-orcid":false,"given":"Gagan D.","family":"Flora","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology\/Oncology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9268-4363","authenticated-orcid":false,"given":"Nirav","family":"Dhanesha","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology\/Oncology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7263-9829","authenticated-orcid":false,"given":"Manish","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology\/Oncology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen R.","family":"Markan","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Pharmacology, University of Iowa, Iowa City, IA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Potthoff","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Pharmacology, University of Iowa, Iowa City, IA; and"},{"name":"Department of Veterans Affairs Medical Center, Iowa City, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8885-4718","authenticated-orcid":false,"given":"Steven R.","family":"Lentz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology\/Oncology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8554-0898","authenticated-orcid":false,"given":"Anil K.","family":"Chauhan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology\/Oncology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"13","key":"2021032515261230500_B1","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa050613","article-title":"A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"2021032515261230500_B2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ahj.2004.03.010","article-title":"The Warfarin\/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure","volume":"148","author":"Cleland","year":"2004","journal-title":"Am Heart J"},{"issue":"4","key":"2021032515261230500_B3","doi-asserted-by":"crossref","first-page":"e0123597","DOI":"10.1371\/journal.pone.0123597","article-title":"Metabolic plasticity in resting and thrombin activated platelets","volume":"10","author":"Ravi","year":"2015","journal-title":"PLoS One"},{"key":"2021032515261230500_B4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.semcdb.2015.08.004","article-title":"Pyruvate kinase: function, regulation and role in cancer","volume":"43","author":"Israelsen","year":"2015","journal-title":"Semin Cell Dev Biol"},{"issue":"29","key":"2021032515261230500_B5","doi-asserted-by":"crossref","first-page":"13807","DOI":"10.1016\/S0021-9258(18)67091-7","article-title":"The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing","volume":"261","author":"Noguchi","year":"1986","journal-title":"J Biol Chem"},{"issue":"48","key":"2021032515261230500_B6","doi-asserted-by":"crossref","first-page":"84276","DOI":"10.18632\/oncotarget.20685","article-title":"Pkm2 can enhance pluripotency in ESCs and promote somatic cell reprogramming to iPSCs","volume":"8","author":"Qin","year":"2017","journal-title":"Oncotarget"},{"issue":"5930","key":"2021032515261230500_B7","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"issue":"1-2","key":"2021032515261230500_B8","first-page":"91","article-title":"Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells","volume":"3","author":"Eigenbrodt","year":"1992","journal-title":"Crit Rev Oncog"},{"issue":"2","key":"2021032515261230500_B9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2013.09.025","article-title":"PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells","volume":"155","author":"Israelsen","year":"2013","journal-title":"Cell"},{"issue":"7","key":"2021032515261230500_B10","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.biocel.2010.02.005","article-title":"Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells","volume":"43","author":"Mazurek","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"2021032515261230500_B11","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.molcel.2012.01.001","article-title":"Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase","volume":"45","author":"Gao","year":"2012","journal-title":"Mol Cell"},{"issue":"1","key":"2021032515261230500_B12","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1038\/ncomms6566","article-title":"PKM2 phosphorylates MLC2 and regulates cytokinesis of tumour cells","volume":"5","author":"Jiang","year":"2014","journal-title":"Nat Commun"},{"issue":"7375","key":"2021032515261230500_B13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature10598","article-title":"Nuclear PKM2 regulates \u03b2-catenin transactivation upon EGFR activation [published correction appears in Nature. 2017;550(7674):142]","volume":"480","author":"Yang","year":"2011","journal-title":"Nature"},{"issue":"4","key":"2021032515261230500_B14","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4049\/jimmunol.1901086","article-title":"Pyruvate kinase M2 promotes expression of proinflammatory mediators in house dust mite-induced allergic airways disease","volume":"204","author":"van de Wetering","year":"2020","journal-title":"J Immunol"},{"key":"2021032515261230500_B15","volume-title":"Probe Reports from the NIH Molecular Libraries Program","author":"Jiang"},{"issue":"4","key":"2021032515261230500_B16","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.celrep.2017.06.083","article-title":"Deletion of GLUT1 and GLUT3 reveals multiple roles for glucose metabolism in platelet and megakaryocyte function [published corrections appear in Cell Rep. 2017;20(9):2277 and Cell Rep. 2017;21(6):1705]","volume":"20","author":"Fidler","year":"2017","journal-title":"Cell Rep"},{"issue":"15","key":"2021032515261230500_B17","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1182\/bloodadvances.2018022392","article-title":"Dichloroacetate, an inhibitor of pyruvate dehydrogenase kinases, inhibits platelet aggregation and arterial thrombosis","volume":"2","author":"Nayak","year":"2018","journal-title":"Blood Adv"},{"issue":"2","key":"2021032515261230500_B18","doi-asserted-by":"crossref","first-page":"H617","DOI":"10.1152\/ajpheart.00667.2010","article-title":"Inducible nitric oxide synthase provides protection against injury-induced thrombosis in female mice","volume":"301","author":"Upmacis","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"8","key":"2021032515261230500_B19","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2012-01-405498","article-title":"Chronic estradiol treatment reduces platelet responses and protects mice from thromboembolism through the hematopoietic estrogen receptor \u03b1","volume":"120","author":"Val\u00e9ra","year":"2012","journal-title":"Blood"},{"issue":"5","key":"2021032515261230500_B20","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/cvr\/cvy044","article-title":"Non-genomic effects of nuclear receptors: insights from the anucleate platelet","volume":"114","author":"Unsworth","year":"2018","journal-title":"Cardiovasc Res"},{"issue":"1","key":"2021032515261230500_B21","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1038\/s41598-017-03031-1","article-title":"PKM2 promotes cell migration and inhibits autophagy by mediating PI3K\/AKT activation and contributes to the malignant development of gastric cancer","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"issue":"14","key":"2021032515261230500_B22","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1182\/blood-2017-03-773614","article-title":"Integrin \u03b1IIb\u03b23 outside-in signaling","volume":"130","author":"Durrant","year":"2017","journal-title":"Blood"},{"issue":"2","key":"2021032515261230500_B23","first-page":"162","article-title":"New Concepts and Mechanisms of Platelet Activation Signaling","volume":"32","author":"Estevez","year":"2017","journal-title":"Physiology (Bethesda)"},{"issue":"3","key":"2021032515261230500_B24","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1172\/JCI105542","article-title":"Studies on human platelet glycolysis. Effect of glucose, cyanide, insulin, citrate, and agglutination and contraction on platelet glycolysis","volume":"46","author":"Karpatkin","year":"1967","journal-title":"J Clin Invest"},{"issue":"4","key":"2021032515261230500_B25","doi-asserted-by":"crossref","first-page":"806","DOI":"10.3324\/haematol.2018.205724","article-title":"Aerobic glycolysis fuels platelet activation: small-molecule modulators of platelet metabolism as anti-thrombotic agents","volume":"104","author":"Kulkarni","year":"2019","journal-title":"Haematologica"},{"issue":"5516","key":"2021032515261230500_B26","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1126\/science.1058079","article-title":"Cooperation and competition in the evolution of ATP-producing pathways","volume":"292","author":"Pfeiffer","year":"2001","journal-title":"Science"},{"key":"2021032515261230500_B27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fonc.2018.00022","article-title":"Posttranslational modifications of pyruvate kinase M2: tweaks that benefit cancer","volume":"8","author":"Prakasam","year":"2018","journal-title":"Front Oncol"},{"issue":"6","key":"2021032515261230500_B28","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.molcel.2011.04.025","article-title":"Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth","volume":"42","author":"Lv","year":"2011","journal-title":"Mol Cell"},{"issue":"6060","key":"2021032515261230500_B29","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1126\/science.1211485","article-title":"Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses","volume":"334","author":"Anastasiou","year":"2011","journal-title":"Science"},{"issue":"3","key":"2021032515261230500_B30","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00441-017-2727-4","article-title":"Platelet-neutrophil interactions as drivers of inflammatory and thrombotic disease","volume":"371","author":"Lisman","year":"2018","journal-title":"Cell Tissue Res"},{"issue":"3","key":"2021032515261230500_B31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrcardio.2017.206","article-title":"Current and future antiplatelet therapies: emphasis on preserving haemostasis","volume":"15","author":"McFadyen","year":"2018","journal-title":"Nat Rev Cardiol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/137\/12\/1658\/1803471\/bloodbld2020007140.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/137\/12\/1658\/1803471\/bloodbld2020007140.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T16:39:45Z","timestamp":1616690385000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/137\/12\/1658\/464168\/The-metabolic-enzyme-pyruvate-kinase-M2-regulates"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,25]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,3,25]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2020007140","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,25]]}}}